Hepion Pharmaceuticals Says Co’s Anti-Cancer Mechanism CRV431 Highlighted In Scripps Research Institute Poster At AASLD, The Liver Meeting 2021
Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence ("AI")-driven therapeutic drug development for the treatment of non-alcoholic